The global drug eruptions market is estimated to be valued US$ 3.89 billion in fiscal year 2023, compared to US$ 3.66 billion in fiscal year 2022. The global market is anticipated to increase steadily from 2023 to 2033 at a 6.2% CAGR, reaching US$ 7.1 billion by the end of that year. Skin sensitivity to …
Category Archives: Healthcare Trends
The Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market Is Expected to Register Growth at 5.2% CAGR through 2033 | FMI Study
In 2023, Eosinophilic Granulomatosis with Polyangiitis Treatment Market is expected to reach a value of US$ 173.8 million at a CAGR of 5.2%. Healthcare technology advancements are expected to drive the market to US$ 288.5 million by 2033. The growing occurrences of churg strauss syndrome and other allergic reactions and asthma, rising geriatric population, and …
Promising Results from Gene Delivery and Enzyme Replacement Therapies to Revolutionize the USA Fucosidosis Therapeutics Market | FMI Predicts 25% of Revenue to Come from North America
According to Future Market Insights, North America is anticipated to hold around 25% share in the global fucosidosis therapeutics market during the forecast period. Within North America, the USA fucosidosis therapeutics market is predicted to exert a domineering influence throughout the projected period. Advanced therapies such as gene therapy and enzyme replacement therapy (ERT) are …
Eisenmenger Complex Management Market to reach US$ 12.9 billion in 2033, Endothelin Receptors to account for 48.1% of all Drugs | FMI Study
The global Eisenmenger complex management market is expected to surpass an impressive valuation of US$ 7.7 billion in 2023 and is projected to reach US$ 12.9 billion by 2033, growing at a CAGR of 5.3%. Generally, the treatment includes relieving the symptoms and associated co-morbidities. Medications such as calcium channel blockers, antiarrhythmic agents, and blood …
Peptide Drug Conjugates Market is projected to expand at a 20% value CAGR by 2033
The global peptide drug conjugates market is expected to be worth US$ 861.12 million in 2023 and US$ 5,331.83 million by 2033. Over the forecast period of 2023 to 2033, the predicted growth rate is about 20%. The growth of the market is attributed to the global upsurge in cancer cases and related mortality, strong …
Continue reading “Peptide Drug Conjugates Market is projected to expand at a 20% value CAGR by 2033”
Bullous Keratopathy Market Value to reach US$ 650 Million by 2033, at a CAGR 4.3%
The global bullous keratopathy market is expected to register a CAGR of 4.3% from 2023 to 2033, reaching a valuation of US$ 427.54 Million in 2023, as per a recently published Future Market Insights report. For the assessment period of 2023 to 2033, a CAGR of 4.3% is expected, with a closing value of US$ …
Continue reading “Bullous Keratopathy Market Value to reach US$ 650 Million by 2033, at a CAGR 4.3%”
Common Warts Market is expected to garner a value of US$ 1100 Million by 2033
A recently published study by FMI expects the global common warts market to augment at a 3.6% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1,100 Million is expected for the market. The increase in pharmaceutical R&D activity for efficient and focused treatment of common warts …
Continue reading “Common Warts Market is expected to garner a value of US$ 1100 Million by 2033”
Genital Warts (Condyloma Acuminatum) Market to expand at a 4.84% value CAGR by 2033
The global genital warts (condyloma acuminatum) market is predicted to be worth US$ 1.87 billion in 2023, rising to US$ 3 billion by 2033 at a CAGR of 4.84%. The global market is expected to benefit from government initiatives and increasing financing for cancer research. The rising expenditure on R&D connected with oncologic disorders, on …
Hypophospatasia Treatment Market is expected to reach US$ 26.27 Million by 2033
In 2023, the global hypophospatasia treatment market size is anticipated to be worth US$ 16.13 million. With rising alcohol consumption, the overall demand for hypophospatasia treatment is expected to expand at a 5.0% CAGR between 2023 and 2033, reaching roughly US$ 26.27 million by 2033. An increase in research and development activities is one of …
Continue reading “Hypophospatasia Treatment Market is expected to reach US$ 26.27 Million by 2033”
Starter Cultures Market is predicted to be valued at US$ 2,154.3 million by 2033
The worldwide sales of starter cultures, which were previously estimated to be worth around US$ 1,123.1 million in 2022, are now expected to boost up. Currently, in the year 2023, the global starter cultures market value is figured out to be around US$ 1,191.6 million. Further, it is expected to develop with a higher average …
Continue reading “Starter Cultures Market is predicted to be valued at US$ 2,154.3 million by 2033”